EUVIMEDEUVIMED entdecken
Querschnittstudie

Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study

Aya Osama Mohamed, HebatAllah Fadel Algebaly, Bola Fathallah Aziz, May Abdelfattah Mohamed, Amira Fathi Srour, Miriam Magdy Aziz, Mohamed Abdallah Abd El Megied

Journal of Pediatric and Neonatal Individualized Medicine · 2026-04 · 15 (1) · e150112-e150112

DOI: 10.7363/150112 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Pediatric and Neonatal Individualized Medicine, 2026-04. Verfasst von Aya Osama Mohamed und 6 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic drug monitoring facilitates the individualiza­tion of amikacin dosing for patients based on pharmacodynamics and pharmacokinetics. Its efficacy is measured by peak serum concentration (Cpeak) / minimum inhibitory concentration (MIC) ratio. This study aims to determine the efficacy of 15 mg/kg/day of amikacin in critically ill septic pediatric patients.

Methods

This cross-sectional analytic study involved 25 pediatric critically ill septic patients. All patients received amikacin based on clinical diagnosis and/or culture results. Amikacin Cpeak and MIC were measured.

Results

Amikacin Cpeak was not achieved in 44% of the study group, with the MIC being at least 64 mcg/mL, leading to a very low Cpeak/MIC ratio.

Conclusion

Critically ill pediatric patients who are administered amikacin require frequent monitoring and dose adjustment to achieve the target level, as subtherapeutic levels may contribute to resistance, while elevated levels are linked to non-oliguric acute kidney injury.

Schlagwörter

amikacincritically illmicsepsistherapeutic drug monitoringpediatrics

Zitieren

APA

Mohamed, A. O., Algebaly, H. F., Aziz, B. F., Mohamed, M. A., Srour, A. F., Aziz, M. M., & Megied, M. A. A. E. (2026). Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study. Journal of Pediatric and Neonatal Individualized Medicine, 15(1), e150112-e150112. https://doi.org/10.7363/150112

Vancouver

Mohamed AO, Algebaly HF, Aziz BF, Mohamed MA, Srour AF, Aziz MM, et al. Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study. Journal of Pediatric and Neonatal Individualized Medicine. 2026;15(1):e150112-e150112. doi:10.7363/150112

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Aya Osama and Algebaly, HebatAllah Fadel and Aziz, Bola Fathallah and Mohamed, May Abdelfattah and Srour, Amira Fathi and Aziz, Miriam Magdy and Megied, Mohamed Abdallah Abd El},
  title = {Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study},
  journal = {Journal of Pediatric and Neonatal Individualized Medicine},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {e150112--e150112},
  doi = {10.7363/150112}
}
Kostenlos starten →